Hormonal therapy resistant estorgen receptor positive metastatic breast cancer cohort study
Not Applicable
- Conditions
- Breast cancer
- Registration Number
- JPRN-UMIN000019556
- Lead Sponsor
- General Incorporated Association of CSPOR-BC
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
A case that corresponds to any of the following is excluded from participating in this study as a subject. (1)HER2-positive breast cancer. (2)A case not indicated for endocrine therapy. (3)Any other case that a physician determines to be unsuitable for participation in this study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical benefit rate
- Secondary Outcome Measures
Name Time Method Progression free survival overall survival time to treatment failure time to chemotherapy response rate health-related quality of life adverse events